LAC Med secures RM28.1 million diagnostic imaging solutions contract in northern Malaysia
The new contract adds to LAC Med Bhd’s momentum in winning projects following its listing in Dec 2025. The implementation period, which runs until August 2027, also strengthens the group’s revenue visibility for the years ahead.
Highlights
- LAC Med Bhd won a RM28.1 million contract to supply a diagnostic imaging solution to a private hospital in northern Peninsular Malaysia, with completion due by 1 August 2027.
- The new contract lifts LAC Med's order book to RM288.1 million from RM230.5 million as of 30 Sept 2026, providing five-year revenue visibility.
- LAC Med shares closed up 4.2% at 75 sen on Monday, unchanged from the IPO price, giving the company a market capitalisation of RM300 million.
This article was translated from the original. Read the original version by our correspondent here.
Contract scope and implementation schedule
As reported by The Edge Malaysia, LAC Med Bhd secured a contract worth RM28.1 million to supply a comprehensive diagnostic imaging solution to a private hospital in the northern region of Peninsular Malaysia.In a statement on Monday, the integrated medical technology solutions provider said its wholly owned subsidiary, LAC Medical Supplies Sdn Bhd, would supply and integrate various modalities across radiology and women's imaging for the unnamed customer.
The work is scheduled for completion by 1 August 2027. After handover, LAC Med will provide ongoing support, including scheduled maintenance and technical assistance.
Group chief executive officer Liew Yoon Poh said the contract marked the start of broader opportunities with the new customer, as the group helps the hospital's clinical teams adopt the technology with confidence.
Impact on order book and growth prospects
The contract marks LAC Med's third win since its listing on 10 Dec 2025, bringing the total value of its post-listing contracts to RM127 million.The new contract lifts its order book to RM288.1 million, up from RM230.5 million as of 30 Sept 2026, the group said. The company added that the development provides revenue visibility for the next five years.
Liew said the group sees broad tender opportunities at public and private hospitals. He said its track record, extensive product portfolio and integration expertise give the company confidence in winning new contracts and translating successful project execution into revenue growth.
LAC Med shares closed up 4.2% at 75 sen on Monday, unchanged from their initial public offering price, giving the company a market capitalisation of RM300 million.
We have also analysed corporate developments at listed companies, including Zetrix AI's sukuk programme.